58 Ibid.
59 AHRP, “Fauci’s Promotional Hype Catapults Gilead’s Remdesivir,” AHRP (May 6, 2020), https://ahrp.org/faucis-promotional-hype-catapults-gileads-remdesivir/
60 Public Citizen, “The Public Already Has Paid for Remdesivir,” Public Citizen, (May 7, 2020), https://www.citizen.org/news/the-public-already-has-paid-for-remdesivir/
61 Umair Irfan, “The FDA approved remdesivir to treat Covid19. Scientists are questioning the evidence.,” Vox (Oct. 24, 2020), https://www.vox.com/21530401/remdesivir-approved-by-fda-covid19-fda-gilead-veklury
62 Jeremy Hsu, “Covid19: What now for remdesivir?,” 371:m4457 BMJ (Nov. 20, 2020), https://www.bmj.com/content/371/bmj.m4457
63 Jon Cohen & Kai Kupferschmidt, “The ‘very, very bad look’ of remdesivir, the first FDA-approved COVID19 drug,” Science (Oct. 28, 2020), https://www.science.org/news/2020/10/very-very-bad-look-remdesivir-first-fda-approved-covid19-drug
64 Umair Irfan, “The FDA approved remdesivir to treat Covid19. Scientists are questioning the evidence,” Vox (Oct. 24, 2020) https://www.vox.com/21530401/remdesivir-approved-by-fda-covid19-fda-gilead-veklury
65 Jon Cohen & Kai Kupferschmidt, “The ‘very, very bad look’ of remdesivir, the first FDA-approved COVID19 drug,” SCIENCE (Oct. 28, 2020), https://www.science.org/news/2020/10/very-very-bad-look-remdesivir-first-fda-approved-covid19-drug
66 Science Media Centre, expert reaction to a study about compassionate use of remdesivir for patients with severe COVID19, (April 11, 2020). https://www.sciencemediacentre.org/expert-reaction-to-a-study-about-compassionate-use-of-remdesivir-for-patients-with-severe-covid19/
67 Ibid.
68 Steven Levy, Bill Gates on Covid: Most US Tests Are ‘Completely Garbage. Wired, (August 7, 2020). https://www.wired.com/story/bill-gates-on-covid-most-us-tests-are-completely-garbage/
69 Owen Dyer, Covid19: Remdesivir has little or no impact on survival, WHO trial shows. BMJ 2020;371:m4057 (Published October 19, 2020). https://www.bmj.com/content/371/bmj.m4057?ijkey=f9301c3ac0aca0af6e1df53f1c90e72b9dc769cd&keytype2=tf_ipsecsha
70 FDA News Release, “FDA Approves First Treatment for COVID19,” FDA (Oct.22, 2020), https://www.fda.gov/news-events/press-announcements/fda-approves-first-treatment-covid19
71 Kari Oakes, “WHO backs off on remdesivir as FDA issues another EUA.” Regulatory Focus (November 19, 2020). https://www.raps.org/news-and-articles/news-articles/2020/11/who-backs-offon-remdesivir-as-fda-issues-another
72 Michael E. Ohl, et al., “Association of Remdesivir Treatment With Survival and Length of Hospital Stay Among US Veterans Hospitalized With COVID19,” JAMA 4(7):e2114741 (2021) doi:10.1001/jamanetworkopen.2021.14741, https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2781959
73 PRAC reviews a signal with Veklury, PRAC (Oct. 2, 2020), https://www.ema.europa.eu/en/news/meeting-highlights-pharmacovigilance-risk-assessment-committee-prac-28-september-1-october-2020
74 “EU medicines agency studies effect of COVID19 drug on kidneys,” Euronews (Oct. 2, 2020), https://www.euronews.com/2020/10/02/eu-medicines-agency-studies-effect-of-covid19-drug-on-kidneys
75 CDC, “Interim Clinical Guidance for Management of Patients with Confirmed Coronavirus Disease (COVID19): Clinical Management and Treatment” Centers for Disease Control and Prevention (Feb. 16, 2120), https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-guidance-management-patients.html
76 NIH, “COVID19 Treatment Guidelines:Therapeutic Management of Hospitalized Adults With COVID19” NIH (Aug 25, 2021), https://www.covid19treatmentguidelines.nih.gov/management/clinical-management/hospitalized-adults--therapeutic-management/
77 NIH, “COVID19 Treatment Guidelines: General Management of Nonhospitalized Patients With Acute COVID19” NIH (Jul. 8, 2021), https://www.covid19treatmentguidelines.nih.gov/management/clinical-management/nonhospitalized-adults--therapeutic-management/
78 Sanna Gevers, et al, ‘Remdesivir in COVID19 Patients with Impaired Renal Function,’ JASN (Feb. 2021) 32 (2) 518-519; DOI: https://doi.org/10.1681/ASN.2020101535
79 Jonathan Grein, M.D., et al, “Compassionate Use of Remdesivir for Patients with Severe Covid19,” N Engl J Med 2020; 382:2327-2336, DOI: 10.1056/NEJMoa2007016 https://www.nejm.org/doi/10.1056/NEJMoa2007016
80 Tavares, Remdesivir is approved for testing on coronavirus patients in Brazil and Europe, https://www.tavaresoffice.com.br/en/remdesivir-is-approved-for-testing-on-coronavirus-patients-in-brazil-and-europe/
81 Lisandra Paraguassu, Ricardo Brito, After record COVID19 deaths, Bolsonaro tells Brazilians to stop ‘whining’, Reuters, (March 5, 2021). https://www.reuters.com/article/us-health-coronavirus-brazil/after-record-covid19-deaths-bolsonaro-tells-brazilians-to-stop-whining-idUSKBN2AX114
82 “Kidney problems more prevalent in NYC COVID19 patients,” Columbia (Jun. 8, 2020), https://www.cuimc.columbia.edu/news/kidney-problems-more-prevalent-nyc-covid-19-patients
Endnotes - Final Solution: Vaccines or Bust
1 Robert Kuznia, “The timetable for a coronavirus vaccine is 18 months. Experts say that’s risky,” CNN (Apr. 1, 2020), https://www.cnn.com/2020/03/31/us/coronavirus-vaccine-timetable-concerns-experts-invs/index.html
2 Stuart A. Thompson, “How Long Will a Vaccine Really Take?,” NYT (Apr. 30, 2020), https://www.nytimes.com/interactive/2020/04/30/opinion/coronavirus-covid-vaccine.html
3 Luke Andrews, ‘It can prevent pneumonia’: Oxford professor running coronavirus vaccine trial comes out in its defence after all of the monkeys given the treatment catch the disease, The Daily Mail, (May 22, 2020). https://www.dailymail.co.uk/sciencetech/article-8347391/It-prevents-pneumonia-Oxford-professor-defences-coronavirus-vaccine.html
4 Sara G. Miller, ‘The looming question’: Fauci says studies suggest vaccines slow virus spread, NBC News, (Feb 17, 2021). https://www.nbcnews.com/health/healthnews/looming-question-fauci-says-studies-suggest-vaccines-slow-virus-spread-n1258142
5 Veronika Kyrylenko, Nobel Prize Winner Warns Vaccines Facilitate Development of Deadlier COVID Variants, Urges Public to Reject Jabs, The New American, (May 20, 2021). https://thenewamerican.com/french-nobel-prize-winner-warns-vaccines-facilitate-development-of-deadlier-covid-variants-urges-the-public-to-reject-jabs/
6 Zane Rizvi, “The NIH Vaccine,” The Public Citizen (Jun. 25, 2020), https://www.citizen.org/article/the-nih-vaccine/#_ftn29
7 Alex Newman, Dr Peter McCullough on Vaccine Death Rate, Raccoon Medicine, (May 29, 2021). https://raccoonmedicine.com/wp/2021/05/29/dr-peter-mccullough-vaccine-death-rate-ignored/